Skip to main content

Heartland Oncology and Hematology Oncologist Named 2025 Advocacy Champion by the Association for Clinical Oncology (ASCO)

Sakeer Hussain, MD, was honored for his dedication to advancing cancer policy at national and state levels during ASCO’s 2025 Advocacy Summit event

COUNCIL BLUFFS, Iowa, May 14, 2025 (GLOBE NEWSWIRE) — Sakeer Hussain, MD, a Board-certified medical oncologist at Heartland Oncology and Hematology, a partner practice of the American Oncology Network (AON), has been recognized as a 2025 Advocacy Champion by the Association for Clinical Oncology (ASCO). The distinction was announced during ASCO’s annual Advocacy Summit held in Washington, D.C. last month.

13404_HOH_Sakeer-Hussain_Press-Release_Headshot_250512_FINAL (1)

Each year, ASCO selects Advocacy Champions who have demonstrated exceptional commitment to policy advocacy in support of high-quality, equitable cancer care. Honorees actively engage lawmakers at both the state and federal levels, champion legislative priorities, and elevate the voice of the oncology community through outreach and education.

“Advocacy Champions like Dr. Hussain are driving real change in how cancer care is delivered across the country,” said Martin Palmeri, MD, MBA, chair of ASCO’s Government Relations Committee and treasurer of the Board of Directors for the Association for Clinical Oncology. “Their efforts this year have advanced critical issues such as drug shortages, securing sustainable research funding, and advocating for permanent telehealth access. These contributions will continue to benefit providers and patients alike.”

Dr. Hussain’s advocacy work spans multiple fronts. During the past year, he has met with congressional leaders in Washington, provided testimony before the Iowa House of Representatives opposing non-medical switching, and hosted his local congressman at his clinic to highlight the value of community oncology care. He has also been a consistent voice in discussions surrounding prior authorization reform and telemedicine expansion.

“I’m deeply honored to be named an ASCO Advocacy Champion,” said Dr. Hussain. “This recognition reflects my commitment to ensuring every cancer patient—regardless of geography, income, or background—has access to the timely, high-quality care they deserve. I believe advocacy is essential to closing gaps in our healthcare system, and I’m proud to contribute to that mission.”

Dr. Stephen “Fred” Divers, chief medical officer of AON, praised the recognition, noting Dr. Hussain’s advocacy impact extends far beyond his own clinic. “Dr Hussain exemplifies the spirit of community oncology and the power of physician-led advocacy,” said Dr. Divers. “His engagement with policymakers helps secure the future of local cancer care and reinforces our network’s mission to support independent practices. We’re proud of his ongoing leadership.”

For news, advocacy, and analysis on cancer policy, please visit www.asco.org/ascoaction.
For more information about AON, visit www.AONcology.com. For more information about Heartland Oncology and Hematology, visit www.heartlandoncology.com.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Heartland Oncology and Hematology
Heartland Oncology and Hematology is a community-based medical oncology and hematology practice providing treatment for patients diagnosed with all types of cancer and blood disorders. Through compassionate care that centers around the patient, Heartland Oncology and Hematology strives to provide the best treatment options, state-of-the-art equipment and best possible experience to patients and their families throughout the healthcare journey. Learn more at www.heartlandoncology.com.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/67cee6cc-5840-4adf-acfb-4f59bfa1361b

CONTACT: Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.